Concepedia

Publication | Open Access

Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin

DOIFull Paper Access

21

Citations

21

References

2012

Year

Lot A. Devriese, Petronella O. Witteveen, J. Wanders, Kenneth Law, G. Edwards, Larisa Reyderman, William Copalu, Fuping Peng, Serena Marchetti, Jos H. Beijnen,
British Journal of Clinical Pharmacology

Abstract

These results indicate that eribulin mesylate may be safely co-administered with compounds that are CYP3A4 inducers.

References

YearCitations

Page 1